Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dennis M. McNamara et al. JCHF 2014;2:

Published byJohannes Saaristo Modified over 5 years ago

Similar presentations

Presentation on theme: "Dennis M. McNamara et al. JCHF 2014;2:"— Presentation transcript:

1 Dennis M. McNamara et al. JCHF 2014;2:551-557
GNB3 Genotype Frequencies in GRAHF (A-HeFT) and the Black and White Subsets From GRACE Frequency of the GNB3 T haplotype is significantly greater in GRAHF (p < 0.001) compared with the white subset from GRACE. A-HeFT = African American Heart Failure Trial; GNB3 = guanine nucleotide-binding proteins (G-proteins) beta-3 subunit; GRACE = Genetic Risk Assessment of Cardiac Events; GRAHF = Genetic Risk Assessment of Heart Failure in African Americans. Dennis M. McNamara et al. JCHF 2014;2: American College of Cardiology Foundation

Download ppt "Dennis M. McNamara et al. JCHF 2014;2:"

Similar presentations

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Beta-Blockers and Outcome in Heart Failure and Atrial.

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Beta-Blockers and Outcome in Heart Failure and Atrial.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Assessing the Risk of Progression From Asymptomatic.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Assessing the Risk of Progression From Asymptomatic.
Stephen W. Waldo et al. JACC 2008;51:

Stephen W. Waldo et al. JACC 2008;51:
Noriko Kikuchi et al. JACEP 2016;2:

Noriko Kikuchi et al. JACEP 2016;2:
Age-related cumulative incidence for (A) serious adverse events (including death, heart failure admission, ventricular arrhythmia and cardiac transplant)

Age-related cumulative incidence for (A) serious adverse events (including death, heart failure admission, ventricular arrhythmia and cardiac transplant)
Hanney Gonna et al. JACEP 2016;2:

Hanney Gonna et al. JACEP 2016;2:
Dean J. Kereiakes et al. JACC 2017;70:

Dean J. Kereiakes et al. JACC 2017;70:
G. Michael Felker et al. JCHF 2014;2:

G. Michael Felker et al. JCHF 2014;2:
Practical Strategies to Reduce HF Hospitalizations in African American Patients.

Practical Strategies to Reduce HF Hospitalizations in African American Patients.
Kenshi Hayashi et al. JACEP 2016;2:

Kenshi Hayashi et al. JACEP 2016;2:
Carolyn Y. Ho et al. JCHF 2015;3:

Carolyn Y. Ho et al. JCHF 2015;3:
Thomas C. Crawford et al. JACEP 2017;3:

Thomas C. Crawford et al. JACEP 2017;3:
Thomas C. Crawford et al. JACEP 2017;j.jacep

Thomas C. Crawford et al. JACEP 2017;j.jacep
Belinda Gray et al. JCHF 2013;1:

Belinda Gray et al. JCHF 2013;1:
Simon W. Rabkin et al. JACEP 2017;j.jacep

Simon W. Rabkin et al. JACEP 2017;j.jacep
Wesley T. O’Neal et al. JACEP 2016;2:

Wesley T. O’Neal et al. JACEP 2016;2:
Jong Sung Park et al. JACEP 2016;2:

Jong Sung Park et al. JACEP 2016;2:
Wayne L. Miller et al. JCHF 2013;1:

Wayne L. Miller et al. JCHF 2013;1:
Mahesh Anantha Narayanan et al. JACEP 2017;3:

Mahesh Anantha Narayanan et al. JACEP 2017;3:
K.R. Julian Chun et al. JACEP 2017;3:

K.R. Julian Chun et al. JACEP 2017;3:

Similar presentations

Ads by Google